Table 3.
Cell Cycle Distribution in Untreated (Control) and Treated HT-29 Cancer Cells with KA39 and Etoposide, at IC50 and TGI Concentrations (μΜ), for 24 and 48 hours, Respectively
| % of Cells in Each Phase of the Cell Cycle at: | ||||||
|---|---|---|---|---|---|---|
| Phases | Control 24 hours |
KA39 IC50 24 hours |
Etoposide IC50 24 hours | Control 48 hours | KA39 TGI 48 hours |
Etoposide TGI 48 hours |
| SG | 18.21% | 27.06% | 20.23% | 15.41% | 33.51% | 55.80% |
| G1 | 65.32% | 46.64% | 57.28% | 64.68% | 40.95% | 26.06% |
| S | 12.00% | 21.52% | 16.50% | 15.59% | 14.66% | 13.10% |
| G2/M | 3.56% | 3.74% | 5.99% | 4.67% | 9.48% | 4.37% |